Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Hypertension × Sunitinib × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Carcinoma, Renal Cell 63 Neoplasm Metastasis 23 Kidney Neoplasms 23 Breast Neoplasms 14 Neoplasms 13 Prostatic Neoplasms 12 Urinary Bladder Neoplasms 9 Melanoma 8 Glioblastoma 8 Gastrointestinal Stromal Tumors 8 Sarcoma 7 Carcinoma, Non-Small-Cell Lung 7 Brain Neoplasms 6 Ovarian Neoplasms 5 Liver Neoplasms 5 Esophageal Neoplasms 5 Colorectal Neoplasms 5 Thyroid Neoplasms 4 Solid Tumors 4 Recurrence 4 Pancreatic Neoplasms 4 Osteosarcoma 4 Lung Neoplasms 4 Leukemia, Myeloid, Acute 4 Carcinoma, Hepatocellular 4 Adenocarcinoma 4 Uveal Melanoma 3 Thymoma 3 Stomach Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3

Interventions

Nutrition Assessment 3 Bevacizumab 3 Lisinopril 2 Labetalol 2 Hydrochlorothiazide 2 Angiotensin-Converting Enzyme Inhibitors 2 ziprasidone 1 pazopanib 1 enzalutamide 1 clevidipine 1 bicalutamide 1 benazepril 1 aliskiren 1 Zolpidem 1 Warfarin 1 Vitamin D 1 Vecuronium Bromide 1 Vancomycin 1 Urine Specimen Collection 1 Tranexamic Acid 1 Tobramycin 1 Thiazides 1 Therapeutics 1 Surveys and Questionnaires 1 Sunitinib 1 Sulindac 1 Standard of Care 1 Spironolactone 1 Sevelamer 1 Rocuronium 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04368546 2021-01-27

Sunitinib Treatment on Tissue Sodium Accumulation (TSS2)

Charite University, Berlin, Germany

Hypertension

Data powered by HemOnc (CC BY 4.0) Colophon ⚡